| Source HCPCS Code |
|
Target NDC Code |
J9351
|
⇄
|
00007-4201-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
|
⇄
|
00007-4201-05
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
|
⇄
|
00069-0075-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
INJECTION, TOPOTECAN, 0.1 MG
|
⇄
|
00078-0674-61
HYCAMTIN (S.D.V.) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/05/2017 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9351
Injection, topotecan, 0.1 mg
|
⇄
|
00409-0302-01
TOPOTECAN HCL 4 MG/4 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9351
|
⇄
|
00409-0302-25
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
Injection, topotecan, 0.1 mg
|
⇄
|
00703-4714-01
TOPOTECAN HCL 4 MG/4 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
05/31/2023 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9351
Injection, topotecan, 0.1 mg
|
⇄
|
00703-4714-71
TOPOTECAN HCL 4 MG/4 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
05/31/2023 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9351
Injection, topotecan, 0.1 mg
|
⇄
|
16729-0151-31
TOPOTECAN HCL 4 MG VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9351
INJECTION, TOPOTECAN, 0.1 MG
|
⇄
|
16729-0243-31
TOPOTECAN (1X4ML;MDV) 1 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
07/01/2020 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9351
|
⇄
|
25021-0206-06
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
|
⇄
|
25021-0206-61
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
INJECTION, TOPOTECAN, 0.1 MG
|
⇄
|
25021-0236-04
TOPOTECAN HCL (1X4ML,PF) 1 MG/ML
|
| Detail Information |
| Relationship Start Date |
01/01/2015 |
| Relationship End Date |
01/31/2021 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9351
|
⇄
|
25021-0824-06
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
INJECTION, TOPOTECAN, 0.1 MG
|
⇄
|
45963-0615-56
TOPOTECAN HCL (SDV,PF) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/13/2015 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9351
|
⇄
|
55390-0370-10
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
|
⇄
|
62756-0023-40
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
Injection, topotecan, 0.1 mg
|
⇄
|
63323-0762-10
TOPOTECAN HCL 4 MG VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9351
|
⇄
|
63323-0762-17
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
|
⇄
|
63323-0762-94
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
INJECTION, TOPOTECAN, 0.1 MG
|
⇄
|
67457-0474-04
TOPOTECAN HYDROCHLORIDE (SINGLE-DOSE,LYOPHILIZED) 4 MG
|
| Detail Information |
| Relationship Start Date |
9/4/2014 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
J9351
INJECTION, TOPOTECAN, 0.1 MG
|
⇄
|
67457-0662-05
TOPOTECAN (SDV) 1 MG/1 ML
|
| Detail Information |
| Relationship Start Date |
04/09/2018 |
| Relationship End Date |
02/28/2022 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9351
Topotecan injection
|
⇄
|
16729-0151-31
Topotecan
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
Topotecan injection
|
⇄
|
16729-0243-31
Topotecan
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
Topotecan injection
|
⇄
|
45963-0615-56
Topotecan
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
Topotecan injection
|
⇄
|
63323-0762-10
Topotecan
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9351
Topotecan injection
|
⇄
|
00409-0302-01
Topotecan
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|